GrowingWithAK

Invesco India Pharma and Healthcare Fund - Direct Plan - Growth

Equity · Sectoral/ Thematic · Direct · Growth

₹8.9700

as of 2026-10-22 · +0.00% vs 2026-10-21

2026-09-10

AMFI archive begins Apr 2006

-11.19%

trough 2026-10-21 (since archive start)

insufficient data

How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Year
2026 · · · · · · · · · -6.5 · · -6.5
Avg · · · · · · · · · · · · ·

All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row.

Equity 79.0%
Other / unclassified 21.0%
Equity split: Large 29.8% Mid 16.4% Small 32.8%

Per AMFI's semi-annual Categorisation of Stocks (top 100 = Large, 101-250 = Mid, 251+ = Small).

  • Large Cap 34.2%
  • Mid Cap 18.9%
  • Small Cap 37.7%
  • Unlisted & other equity 9.2%
· vs · share of this fund's AUM that sits in stocks the index also includes

No holdings data yet for this fund.

Stock Sector % of fund
Max Healthcare Institute Limited Healthcare Services 9.58%
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology 8.99%
Sai Life Sciences Limited Pharmaceuticals & Biotechnology 8.63%
Apollo Hospitals Enterprise Limited Healthcare Services 8.03%
Manipal Health Enterprises Ltd Healthcare Services 7.98%
Divi's Laboratories Limited Pharmaceuticals & Biotechnology 7.85%
Global Health Limited Healthcare Services 7.00%
Dr Agarwals Health Care Limited Healthcare Services 6.32%
Corona Remedies Limited Pharmaceuticals & Biotechnology 6.13%
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology 4.93%
Glenmark Pharmaceuticals Limited Pharmaceuticals & Biotechnology 4.86%
Krishna Institute Of Medical Sciences Limited Healthcare Services 4.72%
Aster DM Quality Care Limited Healthcare Services 1.99%
Healthcare: 100.0%
  • Healthcare 100.0%

Factual data only. No investment advice or recommendation. Read the scheme document and consult a SEBI-registered Investment Adviser for personalised guidance.